Skip to main content
. Author manuscript; available in PMC: 2013 Oct 21.
Published in final edited form as: Cochrane Database Syst Rev. 2008 Jan 23;(1):CD005656. doi: 10.1002/14651858.CD005656.pub2

Summary of findings tables.

1 Complications reported in included studies

Intervention Study ID IOP
Increase		 Glaucoma
treatment		 Cataract
progression		 Reduction
in VA		 IOP
Increase		 Glaucoma
treatment		 Cataract
progression		 Reduction
in VA
Types of intervention Test arm n/N,(%) Control arm n/N (%)
IVTA Sutter 2004 10/34 (29%) 10/34 (29%) 12/28 (43%) 6/34 (18%) 1/35 (3%) 0 (0%) 3/21 (14%) 13/35 (37%)
Avitabile 2005 9/42 (21%) Not reported (NR) 1/42 (2%) NR 0 (0%) NR 0 (0%) NR
Jonas 2006 17/26 (65%) NR NR NR NR NR NR NR
Audren 2006 9/17 (53%) NR 0 (0%) NR NR NR 0 (0%) NR
Steroids implantation Pearson 2002 5/41 (12%) NR 10/41 (24%) 6/41 (14%) 0/28 (0%) NR 1/28 (4%) 1/28 (4%)
Pearson 2005 75/127 (59%) 37/127 (29%) 55/127 (43%) 24/127 (19%) 4/70 (6%) NR NR 11/70 (16%)
Kuppermann 2007 30/201 (15%) NR NR 4/208 (2%) 0 (0%) NR NR 4/105 (4%)